Metallodrugs in cancer nanomedicine
Quim Peña(DWI – Leibniz Institute for Interactive Materials), Twan Lammers(RWTH Aachen University), Orysia Zaremba(Basque Center for Materials, Applications and Nanostructures), Fabian Kießling(Universitätsklinikum Aachen), Roger M. Pallares(RWTH Aachen University), Josbert M. Metselaar(Universitätsklinikum Aachen), Alec Wang(RWTH Aachen University), Stefan Wuttke(Jagiellonian University), Hans W. Scheeren(Universitätsklinikum Aachen), Yang Shi(Guiyang College of Traditional Chinese Medicine)
Cited by 245
Related Papers
Tumor targeting via EPR: Strategies to enhance patient responses
|Advanced Drug Delivery Reviews|2018|1.2k
Smart cancer nanomedicine
|Nature Nanotechnology|2019|1.2k
The Current Status of MOF and COF Applications
|Angewandte Chemie International Edition|2021|1.1k
Tumour-targeted nanomedicines: principles and practice
|British Journal of Cancer|2008|535